The professor in the Division of Lymphoma in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope discussed unanswered questions with regard to DLBCL treatment sequencing.
Alexey Danilov, MD, PhD
Advertisement
The Marianne and Gerhard Pinkus Professor of Early Clinical Therapeutics, medical director of the Early Phase Therapeutics Program for the Systems Clinical Trials Office, co-director of the Toni Stephenson Lymphoma Center, and a professor in the Division of Lymphoma in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, California.
Articles by Alexey Danilov, MD, PhD
Alexey Danilov, MD, PhD, discussed the importance of reassessing sequencing stratagems in the face of a growing toolbox of targeted therapies in DLBCL.
Advertisement
Latest Updated Articles
Alexey Danilov, MD, PhD, on CAR T and Bispecific Antibody Sequencing for DLBCLPublished: July 21st 2025 | Updated:
Advertisement
Advertisement
